Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
70
-
Total 13F shares, excl. options
-
41.6M
-
Shares change
-
-3.24M
-
Total reported value, excl. options
-
$179M
-
Value change
-
-$88.5M
-
Put/Call ratio
-
0
-
Number of buys
-
38
-
Number of sells
-
-43
-
Price
-
$4.31
Significant Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q3 2019
99 filings reported holding GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share as of Q3 2019.
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) has 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41.6M shares
.
Largest 10 shareholders include NEA Management Company, LLC (9.09M shares), BVF INC/IL (7.36M shares), Invesco Ltd. (4.76M shares), WELLINGTON MANAGEMENT GROUP LLP (3.86M shares), Camber Capital Management LP (3.5M shares), BlackRock Inc. (2.93M shares), Redmile Group, LLC (2M shares), VANGUARD GROUP INC (1.75M shares), DIMENSIONAL FUND ADVISORS LP (1.04M shares), and AXA (913K shares).
This table shows the top 70 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.